Barings Supports Gilde Healthcare’s Expansion of Surgical Precision Instruments

Barings, one of the world's leading global alternative investment managers, today announced that it acted as lead lender on senior secured financing for Surgical Precision Instruments GmbH ("SPI"), a MedTech contract development and manufacturing group backed by Gilde Healthcare. The financing supported SPI's acquisitions of Hermann Medizintechnik ("Hermann") and BENTEC Endoscopy ("BENTEC"), refinanced existing facilities and provides additional capacity for further growth.

The acquisitions significantly expand SPI's scale and capabilities. BENTEC adds complementary manufacturing expertise in flexible and semi-flexible endoscopy instruments and Hermann broadens the group's manufacturing capacity and capabilities in implant systems and customised surgical instruments. Following the acquisitions, SPI has more than 500 employees across seven sites in the DACH region, with sales approaching €100 million.

SPI brings together specialist manufacturers serving medical device companies across neurosurgery, minimally invasive surgery, robotics and orthopaedics. Gilde Healthcare has built the group through the acquisitions of Chr. Diener, Koscher & Würtz, Rudischhauser, BENTEC and Hermann, and intends to continue its expansion through organic growth and strategic acquisitions.

About Barings
Barings is a $502 billion* global alternative asset manager that partners with institutional, insurance and wealth clients and supports leading businesses with flexible financing solutions. The firm, a subsidiary of MassMutual with a minority investment from MS&AD, seeks to deliver excess returns by leveraging its global scale and capabilities across credit, real assets, capital solutions and emerging markets.

*As of June 30, 2026

About Gilde Healthcare
Gilde Healthcare is a specialist investor managing over €3.8 billion across three strategies: Venture & Growth in Healthcare, Private Equity in Healthcare and Private Equity in Climate Solutions. Its healthcare private equity strategy invests in profitable lower-mid-market companies in North-Western Europe.

26-5972279

• Share on Twitter
• Share on LinkedIn
• Share via Email